Tyrosine kinase inhibitors are targeted cancer therapies that block the action of enzymes involved in the signaling pathways that regulate cell division and survival. They are crucial in treating various cancers by specifically targeting mutated or overactive tyrosine kinases, thereby minimizing damage to normal cells.